Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Amgen

Dow Jones Rises After Fed Minutes; Meta Breaks Out

Dow Jones rose after the Fed meeting minutes for September were released and the House planned to vote on a new speaker. Meta broke out.

Investors Business Daily

Amgen Stock Surges To 10-Month High, Up 5% On An Unexpected Upgrade

Amgen stock snagged an upgrade Wednesday and surged to a 10-month high as one analyst examined the biotech behemoth's post-Horizon future.

Investors Business Daily

Mirati Therapeutics Snags $5.8 Billion Takeover Deal, But Shares Fall On Lowball Price

Bristol Myers Squibb offered to buy Mirati Therapeutics for up to $5.8 billion, but MRTX stock tumbled on the lowball price.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

All in: Drugmakers say yes, they'll negotiate with Medicare on price, so reluctantly

Despite at least nine lawsuits against the government, all companies whose drugs are up for Medicare price negotiation will come to the bargaining table.

WEKU

Dow Jones Falls 150 Points After Shutdown Averted; Tesla Stock Slides On Weak Deliveries

The Dow Jones fell 150 points Monday, as the U.S. government averted a shutdown. Tesla stock slid on weak Q3 deliveries.

Investors Business Daily

Dow Jones Rallies 200 Points On Cool Inflation Data; Nike Surges On Earnings

The Dow Jones Industrial Average rallied 200 points Friday on a cool inflation report. Nike stock surged on strong earnings results.

Investors Business Daily

Dow Jones Reverses After Jobless Claims, Weak GDP; CarMax Dives On Earnings

The Dow Jones reversed Thursday on initial jobless claims and weak GDP. Used-car retailer CarMax dived on earnings.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Dow Jones Falls After Key Economic Data; Costco Rallies On Earnings

The Dow Jones Industrial Average reversed lower Wednesday after key economic data. Costco stock rallied on strong earnings results.

Investors Business Daily

Dow Jones Slides 250 Points Amid Housing Data; DraftKings Pops On Upgrade

The Dow Jones slid 250 points Tuesday after key housing data. DraftKings rose on an analyst upgrade, while Tesla stock skidded.

Investors Business Daily

Dow Jones Futures Fall: Key Inflation Data Looms As Yields Jump; Tesla Stock In Focus Ahead Of Deliveries

Dow Jones futures: Key inflation data looms this week, while Tesla stock is in focus ahead of the EV giant's Q3 deliveries.

Investors Business Daily

Dow Jones Falls As Market Correction Worsens; 10-Year Treasury Spikes To New High

The Dow Jones Industrial Average dropped Monday, as the market correction worsens. The 10-year Treasury yield spikes to new highs.

Investors Business Daily

Stocks Fall As Oil Nears $100 Per Barrel; Instacart Soars In Debut

Dow Jones fell ahead of the Fed meeting. Instacart jumped on its debut on the Nasdaq.

Investors Business Daily

3 Healthcare Stocks to Buy Today

The POWR Ratings system points the way to 3 of the most attractive healthcare stocks on the market today. Read on below for why you should consider adding these 3 stocks to your portfolio: Johnson & Johnson (JNJ), Amgen (AMGN) and AbbVie (ABBV).

StockNews.com

Amgen Stock Earns Relative Strength Rating Upgrade; Hits Key Threshold

Amgen sees its Relative Strength Rating enter the 80-plus level.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Fortune

Alphabet's Wing CFO Shannon Nash shares her unique path to the C-suite

Nash, who is also an award-winning film producer, names Debbie Allen as one of her greatest mentors.

Investors Business Daily

Why Amgen's $28 Billion Merger News Also Bodes Well For Pfizer, Biogen

Amgen stock rose Friday after the FTC dropped its lawsuit, clearing the way for the biotech to buy Horizon Therapeutics for $28 billion.

Salon

The history of weight loss drugs

"It is no wonder demand for weight-loss drugs continues to soar"

Investors Business Daily

Horizon Therapeutics Jumps On A New FTC Development In The Amgen Takeover Battle

The FTC pulled back one of its efforts to block Amgen's Horizon buyout, according to a document released Friday that sent HZNP stock flying on Monday.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Amgen Stock Scores Relative Strength Rating Upgrade; Hits Key Benchmark

Amgen shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 68 to 80.

The Conversation

Ozempic is in the spotlight but it's just the latest in a long and strange history of weight-loss drugs

Losing weight conveniently, cheaply, safely. That’s been the holy grail of weight-loss ever since 19th century English undertaker and weight-loss celebrity William Banting’s 1863 Letter on Corpulence spruiked his “miraculous” method of slimming down.

Kiplinger

Stock Market Today: Dow Outperforms as Amgen, Boeing Gain Ground

The main benchmarks closed higher ahead of this week's key inflation update.

Investors Business Daily

Dow Jones Reverses Lower On Reports Of Cyberattack; Amazon Soars, Apple Plunges

The Dow Jones reversed lower Friday on reports that hospital systems in multiple states were hit by a cyberattack. Apple tanked on earnings.

Investors Business Daily

Dow Jones Rises After Jobs Report; Carl Icahn Stock Crashes 30% On Dividend Cut

The Dow Jones Industrial Average rose 190 points Friday after the July jobs report. Amazon surged on strong earnings, while Apple stock sold off. Icahn Enterprises crashed.

Investors Business Daily

Amgen Is 'Confident' It Can Wrap The Horizon Takeover By December

Amgen stock jumped Friday after topping Wall Street's second-quarter views, but investors remain zeroed in on the takeover of Horizon.

Investors Business Daily

The Blazing Weight-Loss Drug Battle: Can Anyone Unseat Undisputed Leaders Novo Nordisk And Lilly?

An overweight world is hungry for obesity treatments, driving big forecasts for weight loss drugs. For now, two pharmaceutical stocks own the market.

1 … 6 7 8 9

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations